Chantibody Therapeutics
HOME
OUR COMPANY
  • ABOUT US
  • OUR PLATFORM
  • PUBLICATIONS
CAREER
CONTACT US
Chantibody Therapeutics
HOME
OUR COMPANY
  • ABOUT US
  • OUR PLATFORM
  • PUBLICATIONS
CAREER
CONTACT US
More
  • HOME
  • OUR COMPANY
    • ABOUT US
    • OUR PLATFORM
    • PUBLICATIONS
  • CAREER
  • CONTACT US
  • HOME
  • OUR COMPANY
    • ABOUT US
    • OUR PLATFORM
    • PUBLICATIONS
  • CAREER
  • CONTACT US

AACR 2025 poster #5

MSLN and MUC1 dual-targeting CAR-T with conditional activation and tumor specificity to improve clinical safety and efficacy

Downloads

2025 AACR BZE2203 (pdf)Download

Copyright © 2025 Chantibody Therapeutics - All Rights Reserved.

Powered by